ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models

Science - United States
doi 10.1126/science.1217697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

Science
MultidisciplinaryPhilosophy of ScienceHistory
2013English

Distinct Clinical and Metabolic Deficits in PCA and AD Are Not Related to Amyloid Distribution

Neurology
Neurology
2011English

Lack of BACE1 S-Palmitoylation Reduces Amyloid Burden and Mitigates Memory Deficits in Transgenic Mouse Models of Alzheimer’s Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Translational Therapeutics in Genetically Engineered Mouse Models of Cancer

Cold Spring Harbor Protocols
BiochemistryGeneticsMolecular Biology
2014English

Optimizing Mouse Models of Neurodegenerative Disorders: Are Therapeutics in Sight?

Future Neurology
Neurology
2014English

Glutamate N-Methyl-D-Aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

Biological Psychiatry
Biological Psychiatry
2011English

Neuropeptide Y Mitigates Neuropathology and Motor Deficits in Mouse Models of Machado–Joseph Disease

Human Molecular Genetics
MedicineGeneticsMolecular Biology
2015English

Neurodegeneration: How Immune Cells Clear Amyloid

Nature
Multidisciplinary
2016English

Protective Effects of Akkermansia Muciniphila on Cognitive Deficits and Amyloid Pathology in a Mouse Model of Alzheimer’s Disease

Nutrition and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy